The 2023 BioTechX event, which took place in Basel, Switzerland, focused on digital transformation in healthcare using artificial intelligence and precision medicine. Panelists from major corporations, such as Takeda, Novartis, and Johnson & Johnson, discussed the importance of data-driven decision-making for improved health outcomes. They emphasized the need for companies to go digital and adopt transforming strategies. Digital technologies, digital twins, and augmented intelligence were presented as effective tools in drug discovery, supply chain optimization, and patient care. Successful digital transformation was linked to strategic clarity, employee education, showcasing early wins, and aligning ROI expectations.
Tariff support for health IT launched in South Korea following Trump’s tariff and more briefs
The South Korean government has launched a tariff support center to assist medical device companies with trade challenges, particularly related to U.S. tariffs. Meanwhile, Johnson
